EVO logo

Evotec SE (EVO) Cash From Financing

Annual CFF

$77.91 M
+$133.18 M+240.94%

December 31, 2023

Summary

Performance

1-Year Change

+240.94%

3-Year Change

-72.31%

5-Year Change

+184.84%

15-Year Change

-71.42%

EVO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.12%
EVO annual cash flow from financing activities is higher than 83.12% of companies in Healthcare sector

High & Low

All-time High

$471.41 M
EVO annual cash flow from financing activities is currently -83.47% below its historical high of $471.41 million

3-Year Low

-$55.28 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 24, 2025
EVO next annual earnings announcement is scheduled for Apr 24, 2025

OtherEVOcash flowmetrics:

Annual CFI

-$14.39 M
EVO annual cash flow from investing activities is -$14.39 million

Annual CFO

$39.45 M
EVO annual cash flow from operations is $39.45 million

Annual FCF

-$194.39 M
EVO annual free cash flow is -$194.39 million

Annual CAPEX

$233.84 M
EVO annual capital expenditures is $233.84 million

Quarterly CFF

-$10.78 M
+$117.34 M+91.58%

September 1, 2024

Summary

Performance

3-Month Change

+91.58%

1-Year Change

-123.23%

3-Year Change

-82%

5-Year Change

-82%

EVO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

10.86%
EVO quarterly cash flow from financing activities is higher than 10.86% of companies in Healthcare sector

High & Low

All-time High

$473.43 M
EVO quarterly cash flow from financing activities is currently -102.28% below its historical high of $473.43 million

3-Year Low

-$128.12 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
EVO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
EVO next earnings announcement is scheduled for Apr 24, 2025

OtherEVOcash flowmetrics:

Quarterly CFI

-$29.94 M
EVO quarterly cash flow from investing activities is -$29.94 million

Quarterly CFO

$44.58 M
EVO quarterly cash flow from operations is $44.58 million

Quarterly FCF

$11.60 M
EVO quarterly free cash flow is $11.60 million

Quarterly CAPEX

$32.98 M
EVO quarterly capital expenditures is $32.98 million

TTM CFF

-$120.57 M
-$57.19 M-90.23%

September 1, 2024

Summary

Performance

3-Month Change

-90.23%

1-Year Change

-382.34%

3-Year Change

-127.56%

5-Year Change

-127.56%

EVO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.49%
EVO TTM cash flow from financing activities is higher than 8.49% of companies in Healthcare sector

High & Low

All-time High

$465.00 M
EVO TTM cash flow from financing activities is currently -125.93% below its historical high of $465.00 million

3-Year Low

-$120.57 M
EVO TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
EVO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
EVO next earnings announcement is scheduled for Apr 24, 2025

OtherEVOcash flowmetrics:

TTM CFI

-$129.49 M
EVO TTM cash flow from investing activities is -$129.49 million

TTM CFO

-$40.10 M
EVO TTM cash flow from operations is -$40.10 million

TTM FCF

-$228.52 M
EVO TTM free cash flow is -$228.52 million

TTM CAPEX

$188.42 M
EVO TTM capital expenditures is $188.42 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

EVO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+240.9%-123.2%-382.3%
3 y3 years-72.3%-82.0%-127.6%
5 y5 years+184.8%-82.0%-127.6%

EVO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-83.5%+240.9%-102.3%+91.6%-125.9%at low
5 y5-year-83.5%+240.9%-102.3%+91.6%-125.9%at low
alltimeall time-83.5%+184.8%-102.3%+91.6%-125.9%at low

Evotec SE Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.78 M(-91.6%)
-$120.57 M(+90.2%)
Jun 2024
-
-$128.12 M(+1909.1%)
-$63.38 M(-184.2%)
Mar 2024
-
-$6.38 M(-125.8%)
$75.26 M(-3.4%)
Dec 2023
$77.91 M(-240.9%)
$24.71 M(-46.7%)
$77.91 M(+82.4%)
Sep 2023
-
$46.41 M(+341.0%)
$42.70 M(-843.9%)
Jun 2023
-
$10.52 M(-381.8%)
-$5.74 M(-90.3%)
Mar 2023
-
-$3.73 M(-64.4%)
-$59.13 M(-3.6%)
Dec 2022
-$55.28 M(-111.7%)
-$10.49 M(+415.4%)
-$61.32 M(-114.5%)
Sep 2022
-
-$2.04 M(-95.3%)
$422.60 M(+5.3%)
Jun 2022
-
-$42.87 M(+623.6%)
$401.19 M(-8.3%)
Mar 2022
-
-$5.92 M(-101.3%)
$437.47 M(-5.9%)
Dec 2021
$471.41 M(+67.5%)
$473.43 M(-2119.7%)
$465.00 M(+74.3%)
Sep 2021
-
-$23.44 M(+255.5%)
$266.82 M(-7.3%)
Jun 2021
-
-$6.59 M(-130.5%)
$287.70 M(-6.3%)
Mar 2021
-
$21.61 M(-92.2%)
$306.99 M(+9.1%)
Dec 2020
$281.41 M(+19.0%)
$275.25 M(<-9900.0%)
$281.41 M(+1102.9%)
Sep 2020
-
-$2.57 M(-120.2%)
$23.39 M(-2075.7%)
Jun 2020
-
$12.70 M(-419.5%)
-$1.18 M(-100.5%)
Mar 2020
-
-$3.98 M(-123.1%)
$219.89 M(-7.0%)
Dec 2019
$236.51 M(-357.6%)
$17.24 M(-163.5%)
$236.51 M(+34.0%)
Sep 2019
-
-$27.15 M(-111.6%)
$176.51 M(-9.3%)
Jun 2019
-
$233.78 M(+1749.4%)
$194.55 M(-374.6%)
Mar 2019
-
$12.64 M(-129.6%)
-$70.84 M(-22.8%)
Dec 2018
-$91.82 M(-133.7%)
-$42.76 M(+369.6%)
-$91.82 M(+140.6%)
Sep 2018
-
-$9.11 M(-71.2%)
-$38.17 M(-124.5%)
Jun 2018
-
-$31.62 M(+279.1%)
$155.57 M(-18.1%)
Mar 2018
-
-$8.34 M(-176.6%)
$190.00 M(-30.3%)
Dec 2017
$272.62 M(-1352.2%)
$10.89 M(-94.1%)
$272.62 M(+9.6%)
Sep 2017
-
$184.63 M(+6461.8%)
$248.74 M(+315.5%)
Jun 2017
-
$2.81 M(-96.2%)
$59.87 M(+13.6%)
Mar 2017
-
$74.28 M(-672.0%)
$52.68 M(-342.0%)
Dec 2016
-$21.77 M
-$12.99 M(+206.2%)
-$21.77 M(+176.2%)
Sep 2016
-
-$4.24 M(-3.0%)
-$7.88 M(+180.5%)
Jun 2016
-
-$4.37 M(+2423.6%)
-$2.81 M(-243.2%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$173.20 K(-119.2%)
$1.96 M(-28.9%)
Dec 2015
$2.76 M(-33.0%)
$903.90 K(+8.9%)
$2.76 M(+29.4%)
Sep 2015
-
$830.40 K(+107.4%)
$2.13 M(-14.6%)
Jun 2015
-
$400.40 K(-35.8%)
$2.50 M(-50.5%)
Mar 2015
-
$624.00 K(+125.6%)
$5.04 M(+22.4%)
Dec 2014
$4.12 M(-90.3%)
$276.60 K(-76.9%)
$4.12 M(-30.2%)
Sep 2014
-
$1.20 M(-59.4%)
$5.90 M(-86.9%)
Jun 2014
-
$2.94 M(-1085.3%)
$44.92 M(+6.2%)
Mar 2014
-
-$298.70 K(-114.5%)
$42.29 M(-0.3%)
Dec 2013
$42.41 M(-8409.9%)
$2.06 M(-94.9%)
$42.41 M(+16.8%)
Sep 2013
-
$40.22 M(>+9900.0%)
$36.32 M(-1298.3%)
Jun 2013
-
$318.00 K(-277.2%)
-$3.03 M(-8.6%)
Mar 2013
-
-$179.50 K(-95.5%)
-$3.32 M(+550.0%)
Dec 2012
-$510.40 K(-117.1%)
-$4.03 M(-568.6%)
-$510.40 K(-106.7%)
Sep 2012
-
$860.00 K(+2604.4%)
$7.59 M(+22.2%)
Jun 2012
-
$31.80 K(-98.8%)
$6.21 M(+12.1%)
Mar 2012
-
$2.63 M(-35.4%)
$5.54 M(+85.8%)
Dec 2011
$2.98 M(-166.8%)
$4.07 M(-887.7%)
$2.98 M(-160.0%)
Sep 2011
-
-$516.40 K(-19.0%)
-$4.97 M(+17.1%)
Jun 2011
-
-$637.50 K(-1032.0%)
-$4.24 M(+12.0%)
Mar 2011
-
$68.40 K(-101.8%)
-$3.79 M(-15.1%)
Dec 2010
-$4.46 M(-310.6%)
-$3.88 M(-1966.9%)
-$4.46 M(-187.5%)
Sep 2010
-
$208.00 K(-213.5%)
$5.10 M(+5.7%)
Jun 2010
-
-$183.30 K(-69.7%)
$4.82 M(+72.1%)
Mar 2010
-
-$604.70 K(-110.6%)
$2.80 M(+32.2%)
Dec 2009
$2.12 M(-133.5%)
$5.68 M(-8426.1%)
$2.12 M(-159.6%)
Sep 2009
-
-$68.20 K(-96.9%)
-$3.56 M(+2.0%)
Jun 2009
-
-$2.20 M(+71.2%)
-$3.49 M(+171.2%)
Mar 2009
-
-$1.29 M(-38.5%)
-$1.29 M(-38.5%)
Dec 2008
-$6.32 M(+361.3%)
-
-
Mar 2008
-
-$2.09 M
-$2.09 M
Dec 2007
-$1.37 M(-106.9%)
-
-
Dec 2006
$19.92 M(-38.3%)
-
-
Dec 2005
$32.28 M
-
-

FAQ

  • What is Evotec SE annual cash flow from financing activities?
  • What is the all time high annual CFF for Evotec SE?
  • What is Evotec SE annual CFF year-on-year change?
  • What is Evotec SE quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Evotec SE?
  • What is Evotec SE quarterly CFF year-on-year change?
  • What is Evotec SE TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Evotec SE?
  • What is Evotec SE TTM CFF year-on-year change?

What is Evotec SE annual cash flow from financing activities?

The current annual CFF of EVO is $77.91 M

What is the all time high annual CFF for Evotec SE?

Evotec SE all-time high annual cash flow from financing activities is $471.41 M

What is Evotec SE annual CFF year-on-year change?

Over the past year, EVO annual cash flow from financing activities has changed by +$133.18 M (+240.94%)

What is Evotec SE quarterly cash flow from financing activities?

The current quarterly CFF of EVO is -$10.78 M

What is the all time high quarterly CFF for Evotec SE?

Evotec SE all-time high quarterly cash flow from financing activities is $473.43 M

What is Evotec SE quarterly CFF year-on-year change?

Over the past year, EVO quarterly cash flow from financing activities has changed by -$57.19 M (-123.23%)

What is Evotec SE TTM cash flow from financing activities?

The current TTM CFF of EVO is -$120.57 M

What is the all time high TTM CFF for Evotec SE?

Evotec SE all-time high TTM cash flow from financing activities is $465.00 M

What is Evotec SE TTM CFF year-on-year change?

Over the past year, EVO TTM cash flow from financing activities has changed by -$163.27 M (-382.34%)